Under the title “Holistic pro-Inflammatory Target for Sight (HITS)” the Ophthalmology Pivotal Meeting kicked off in Saudi ...

Zurich (Switzerland), May 14, 2025- GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients ...

President Donald Trump signed an Executive Order (EO) titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients” aimed ...

As the life sciences field evolves, organizations must ensure career paths in research and development are keeping up.

In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment commitments, with the biomedical sector ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the "Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Upside risks include the potential unfreezing of U.S. aid to Malawi, easing of trade restrictions, faster-than-expected development of mining mega-projects, and the rapid conclusion of ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

Presented by The Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care   The Big Story PhRMA warns ...

The MOU aims to collaborate on enhancing public health services, awareness programs, and advancing disease management ...